VCs are lurking around what some consider the next frontier of the delivery sector: pharmaceuticals. A regulatory change means a bevy of startups offering prescription
VCs are lurking around what some consider the next frontier of the delivery sector: pharmaceuticals. A regulatory change means a bevy of startups offering prescription
